Abraham Bassan
Director/Board Member at CARGO THERAPEUTICS, INC.
Net worth: - $ as of 31/03/2024
Profile
Abraham Bassan was the founder of Aurora Medical Group, Inc. (founded in 2012) where he served as the Chief Executive Officer from 2012 to 2014.
He is currently working as a Director at Vedere Bio II, Inc., Cargo Therapeutics, Inc., Septerna, Inc., and Link Cell Therapies, Inc. He is also the President & Director of Link Cell Therapies, Inc. Additionally, Mr. Bassan is a Principal at Samsara Biocapital LLC since 2017.
In his former positions, he worked as an Associate Director-Program Development at bluebird bio, Inc. from 2010 to 2012, Director-Program Biology at Revolution Medicines, Inc. from 2015 to 2017, and as an Associate at Third Rock Ventures LLC from 2009 to 2010.
Mr. Bassan obtained his graduate degree from Stanford University in 2008 and his undergraduate degree from Princeton University in 2008.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 01/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Abraham Bassan active positions
| Companies | Position | Start |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Director/Board Member | 01/02/2021 |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Director/Board Member | 01/04/2021 |
Septerna, Inc.
 Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Director/Board Member | 01/11/2021 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01/07/2017 |
Former positions of Abraham Bassan
| Companies | Position | End |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Corporate Officer/Principal | 01/07/2017 |
| Aurora Medical Group, Inc. | Chief Executive Officer | 01/09/2014 |
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | 01/08/2012 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 01/05/2010 |
| LENZ THERAPEUTICS, INC. | Director/Board Member | - |
Training of Abraham Bassan
| Stanford University | Graduate Degree |
| Princeton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
| Aurora Medical Group, Inc. | |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Commercial Services |
Septerna, Inc.
Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
- Stock Market
- Insiders
- Abraham Bassan
